SECURING ADVANTAGES IN GLOBAL MARKETS: THE EXAMPLE OF STEM CELL TECHNOLOGYExpressO (2012)
AbstractThe potential of innovation to spur economic growth is central to determining how markets in new medical developments, such as stem cell technology, can be maximised within Europe and the USA. Promoting innovation is reliant upon nurturing technological development and at root this necessitates an effective regulatory environment. Existing academic discourse generally fragments the regulatory landscape to consider the effectiveness of discrete aspects of oversight measures and systems. This article argues that working towards a regulatory landscape which effectively shepherds technology to interim- and end-consumers in order to maximise market potential must begin from an understanding of the interrelationship of regulation in a practical context. Adopting a holistic approach, new pressure points emerge from exploring this interrelationship and this identifies the potential for remedial measures to be more effectively directed and more realistically assessed. Incorporating a comparative analysis between Europe and the USA, as two of the leading medical innovators globally, enables new insights to be made about how minor differences in regulation can result in pressure points arising at entirely different junctures. This analysis also enables conclusions to be reached about how the most successful aspects of the existing landscape are often entirely overlooked within regulation discourse.
- stem cells,
- comparative analysis,
- abuse of rights
Publication DateOctober 10, 2012
Citation InformationAmanda Warren-Jones. "SECURING ADVANTAGES IN GLOBAL MARKETS: THE EXAMPLE OF STEM CELL TECHNOLOGY" ExpressO (2012)
Available at: http://works.bepress.com/amanda_warren-jones/1/